comments please, page-2

Hi Druiner

The bulk of the negative cash flow would have related to the purchase of Advangen Japan for a combination of shares and cash. This would have included the purchase of $550K cash held by Advangen Japan for $550K. The purchase of cash (with cash) was not an operational item however the purchase of inventory held by Advangen Japan probably was.

The June Quarterly was a one off containing multiple swings and roundabouts in compliance with the accounting standards.
The September quarterly will provide a clearer operational picture.

Cash plus PEB shares (in hand) should be pretty good ATM.

One of PEB's bladder cancer diagnostic competitors in the US may be closing from what I hear. Some (blogging) salesmen are referring affected clinicians to the CX Bladder product. It's a rough world out there if you can't demonstrate sufficient statistical accuracy to remove the need for more invasive and costly procedures and thus keep the Medicare insurers happy.

cheers